Search for: "Biogen Idec, Inc." Results 1 - 20 of 113
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Dec 2019, 9:59 pm by Patent Docs
For example, in Classen Immunotherapies, Inc. v. [read post]
22 Mar 2016, 6:12 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
14 Mar 2016, 3:23 am
Never too late 85 [week ending on Sunday 28 February] – AG Yves Bot's take in Reha Training | Battistelli having hard times | Blocking injunctions in trade mark cases | AIPPI UK event | Patent Enforcement Worldwide | Why Mickey Mouse is not mickey mouse | UPC court fees.Never too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In… [read post]
7 Mar 2016, 1:55 am
**********PREVIOUSLY, ON NEVER TOO LATENever too late 85 [week ending on Sunday 28February] – AG Yves Bot's take in Reha Training | Battistelli having hard times | Blocking injunctions in trade mark cases | AIPPI UK event | Patent Enforcement Worldwide| Why Mickey Mouse is not mickey mouse | UPC court fees.Never too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In… [read post]
29 Feb 2016, 11:27 pm
**********PREVIOUSLY, ON NEVER TOO LATENever too late 84 [week ending on Sunday 21 February] – Domain Name Law and Practice | Unwired Planet v Huawei and Samsung | In memoriam of Justice Antonin Scalia | Celltrion Inc. v Biogen Idec Inc., F. [read post]
23 Feb 2016, 1:53 am
 * English Patent Court speeds up, reminds Mr Justice Carr in Celltrion v BiogenCelltrion Inc. v Biogen Idec Inc., F. [read post]
17 Feb 2016, 12:19 am
Always a fan of a case management decision, the AmeriKat was interested to see the decision in Celltrion Inc. v Biogen Idec Inc., F. [read post]
13 Aug 2015, 10:56 am
Biogen Idec, Inc. is a case involving a brand-name pharmaceutical product which held that design defect claims against drug manufacturers are preempted as a matter of law. [read post]